Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03934255 · ClinicalTrials.gov registry record · NA
Circadian Mechanisms Underlying Non-Dipping Blood Pressure in Blacks
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03934255 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 32 participants.
The verdict
NCT03934255, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study seeks to examine central and peripheral circadian mechanisms in Blacks with appropriately dipping systolic blood pressure (blood pressure that dips by at least 10%) compared with non-dipping systolic blood pressure (blood pressure that dips by less than 10%) using a constant routine protocol. Constant routine protocols are commonly used in the field of circadian biology to examine rhythms in biological processes while controlling the entraining effects of light, activity, and diet.
Interventions
- OTHER Constant Routine Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03934255
The ClinicalTrials.gov registry entry for NCT03934255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Constant Routine Protocol is the first listed.
NCT03934255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03934255 about?
NCT03934255 is a clinical study titled "Circadian Mechanisms Underlying Non-Dipping Blood Pressure in Blacks". This study seeks to examine central and peripheral circadian mechanisms in Blacks with appropriately dipping systolic blood pressure (blood pressure that dips by at least 10%) compared with non-dipping systolic blood pressure (blood pressure that dips by less than 10%) using a constant routine proto...
What is the current status of trial NCT03934255?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2020-01-01. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT03934255?
The interventions under investigation include: Constant Routine Protocol (OTHER).
Who is sponsoring clinical trial NCT03934255?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.